InvestorsHub Logo
Followers 16
Posts 1524
Boards Moderated 0
Alias Born 08/09/2011

Re: None

Tuesday, 05/03/2016 3:01:16 PM

Tuesday, May 03, 2016 3:01:16 PM

Post# of 4218
Unlike the rest of the Board of Directors, Cartwright comes from a medical management background with big companies in big cities. His long term reputation is at stake. The company obviously didn't take instruction very well from the previous time LuViva was denied. We'll see in the next twelve months whether or not the real problem was the former FDA reviewer, the product itself, or the company's inability to follow FDA guidance.
Continuous data gathering from Turkey and other markets can't hurt the company's position with the FDA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GTHP News